Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$134.00

-6.09 (-4.35%)

12:55
07/12/19
07/12
12:55
07/12/19
12:55

J&J tells Reuters implication of new development is 'flatly wrong'

Johnson & Johnson told Reuters following Bloomberg's report of a U.S. criminal probe into its baby powder risk denials that any implication of a new development in the matter is "flatly wrong." Reference Link

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

JNJ Johnson & Johnson
$134.00

-6.09 (-4.35%)

07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/19
JEFF
07/11/19
NO CHANGE
Target $40
JEFF
Buy
Australia implants decision a 'big positive' for Establishment, says Jefferies
After Australia's Therapeutic Goods Administration proposed to cancel or suspend use of textured breast implants, concluding that these devices are associated with a higher rate of anaplastic large cell lymphoma, or ALCL, Jefferies analyst Raj Denhoy called the decision a "big positive" for Establishment Labs (ESTA). The decision is still in the proposal stage, but Establishment is the only manufacturer with products approved in Australia that is not on the list, which proposes to ban implants from Allergan (AGN), J&J's (JNJ) Mentor and other manufacturers, according to Denhoy. He keeps a Buy rating and $40 price target on shares of Establishment Labs.
07/12/19
FBCO
07/12/19
INITIATION
Target $156
FBCO
Outperform
Johnson & Johnson assumed with an Outperform at Credit Suisse
Credit Suisse analyst Matt Miksic assumed coverage of Johnson & Johnson with an Outperform rating and $156 price target. In a research note to investors, Miksic cites key drivers to the rating, including continued growth in Immunology, driven by Stelera and Tremfya, sustainable growth in Oncology driven by Imbruvica, Darzelex and Erleada, an "attractive" pipeline of filings in the 2019-2023 timeframe with greater than$1B potential each, and "stable" growth and cash flows in Medical Devices and Consumer.
07/12/19
WELS
07/12/19
NO CHANGE
Target $29
WELS
Outperform
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
Wells Fargo analyst David Maris believes Australia's proposal to ban, suspend or impose strict restrictions on a number of textured implants from Allergan (AGN), Johnson & Johnson (JNJ) and other smaller manufacturers is "excellent news" for Establishment Labs Holdings (ESTA). The move by Australia's regulatory body Therapeutic Goods Administration will help solidify Establishment's reputation for safety as the company's Motiva brand is the only listed company without any restricted brands, Maris tells investors in a research note. Further, Australia is a highly regulated and developed market, so the ban could help shift market share in other geographies outside of the county as well, contends the analyst. Maris reiterates an Outperform rating on Establishment Labs with a $29 priced target. The stock closed yesterday up $1.54 to $22.44.

TODAY'S FREE FLY STORIES

LYFT

Lyft

$51.31

-2.83 (-5.23%)

07:51
08/23/19
08/23
07:51
08/23/19
07:51
Recommendations
Lyft analyst commentary  »

JPMorgan keeps Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

07:49
08/23/19
08/23
07:49
08/23/19
07:49
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

LNDC

Landec

$10.99

-0.07 (-0.63%)

07:48
08/23/19
08/23
07:48
08/23/19
07:48
Initiation
Landec initiated  »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:41
08/23/19
08/23
07:41
08/23/19
07:41
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware investors will…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

WMT

Walmart

$111.90

-0.11 (-0.10%)

, TSLA

Tesla

$222.07

1.18 (0.53%)

07:39
08/23/19
08/23
07:39
08/23/19
07:39
Periodicals
Walmart, Tesla seek to resolve issues surrounding solar systems, Reuters reports »

Walmart (WMT) and Tesla…

WMT

Walmart

$111.90

-0.11 (-0.10%)

TSLA

Tesla

$222.07

1.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AAPL

Apple

$212.55

-0.14 (-0.07%)

07:38
08/23/19
08/23
07:38
08/23/19
07:38
Periodicals
Apple contractors listened to 1,000 Siri recordings a day, Irish Examiner says »

Jess Casey of the Irish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$19.33

-0.72 (-3.59%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 21

    Nov

CRM

Salesforce

$148.26

0.86 (0.58%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

, MDR

McDermott

$4.39

0.24 (5.78%)

07:35
08/23/19
08/23
07:35
08/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

MDR

McDermott

$4.39

0.24 (5.78%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DKS

Dick's Sporting

$34.14

1.17 (3.55%)

07:34
08/23/19
08/23
07:34
08/23/19
07:34
Recommendations
Dick's Sporting analyst commentary  »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RTRX

Retrophin

$13.55

-3.84 (-22.08%)

07:29
08/23/19
08/23
07:29
08/23/19
07:29
Recommendations
Retrophin analyst commentary  »

Retrophin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

CRM

Salesforce

$148.26

0.86 (0.58%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
Salesforce analyst commentary at Canaccord »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

07:27
08/23/19
08/23
07:27
08/23/19
07:27
Conference/Events
Federal Reserve Chairman Jerome Powell speaks at symposium »

Federal Reserve Chairman…

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Conference/Events
Federal Reserve Bank of St. Louis president to be interviewed »

James Bullard, President…

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

TGI

Triumph Group

$22.70

0.19 (0.84%)

07:22
08/23/19
08/23
07:22
08/23/19
07:22
Downgrade
Triumph Group rating change  »

Triumph Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:22
08/23/19
08/23
07:22
08/23/19
07:22
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

WAL

Western Alliance

$43.59

0.025 (0.06%)

07:18
08/23/19
08/23
07:18
08/23/19
07:18
Recommendations
Western Alliance analyst commentary  »

Western Alliance added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MCD

McDonald's

$219.39

-1.29 (-0.58%)

, QSR

Restaurant Brands

$75.43

0.21 (0.28%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
McDonald's, Restaurant Brands, Carrols Restaurant analyst commentary at Stephens »

McDonald's…

MCD

McDonald's

$219.39

-1.29 (-0.58%)

QSR

Restaurant Brands

$75.43

0.21 (0.28%)

TAST

Carrols Restaurant

$7.07

-0.2 (-2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 05

    Sep

  • 23

    Sep

  • 13

    Nov

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:14
08/23/19
08/23
07:14
08/23/19
07:14
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary at Oppenheimer »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

ARMK

Aramark

$39.93

0.22 (0.55%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Initiation
Aramark initiated  »

Aramark initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRGB

Red Robin

$32.96

-0.64 (-1.90%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Earnings
Red Robin cuts FY19 adj. EPS view to 95c-$1.50 from $1.14-$1.77 »

Consensus $1.14. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

CDNA

CareDx

$23.56

-0.16 (-0.67%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07
Recommendations
CareDx analyst commentary at H.C. Wainwright »

CareDx draft LCD should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.